Vaccine uptake in low- and middle-income countries is generally explained by a desire for personal protection against COVID-19, despite the most common reason for hesitancy being adverse side effects after vaccination. Given the day-to-day interactions with myriads of patients, health care professionals are one of the eligible groups of the community to receive the vaccine with priority. As per the National Deployment and Vaccination Plan (NDVP) of Ethiopia, developed following the WHO Prioritizing Roadmap, the first candidates to receive this vaccine are population groups with relatively higher risk of contracting the virus. It has been few months since Ethiopia launched the Oxford AstraZeneca vaccine for COVID-19 and aimed to vaccinate 20% of the population by the end of 2021. Furthermore, it is expected to be mass-produced and may play an important role in curbing the pandemic. Unlike many other vaccines, which are costly and must be stored at extremely low temperatures, the Oxford–AstraZeneca vaccine can be stored in a regular refrigerator and costs only a few dollars per dose. Inactivated whole-virus vaccines: BBIBP-CorV (Sinofarm) and CoronaVac (Sinovac Life Sciences). 4 Across the globe, there are three major categories of COVID-19 vaccines until the end of June 2021:
To date, the scientific community is working collaboratively and aggressively to develop an efficient and effective vaccine against the SARS-CoV-2 virus with minimal side effects and complications. The plan also focuses on strengthening researches and innovation for the effective delivery of safe vaccines as part of the overall strategy to successfully confront the COVID-19 pandemic. 2 To overcome the ongoing challenges, the WHO has created Strategic Preparedness and Response Plan 2021 (SPRP2021) which translates the previously learned knowledge into coordinated action. 1 Besides this, the pandemic has brought the worst global economic contraction of the past 80 years through its multi-sectoral impact such as unemployment, poverty, human development, investment, trade, tourism, transport, manufacturing industries, commodity prices, small and medium-sized enterprises. On a similar date of access, there have been 275,935 confirmed cases of COVID- deaths reported in Ethiopia. Globally, as of 28 June 2021, a total of 180,817,269 confirmed cases of COVID-19, including 3,923,238 deaths were reported to World Health Organization (WHO).
0 kommentar(er)
